European Heart Journal Advance Access published online on January 22, 2007
European Heart Journal, doi:10.1093/eurheartj/ehl439
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Attenuation of cardiac remodelling by endocardial injection of erythropoietin: ultrasonic strain-rate imaging in a model of hibernating myocardium
1 Department of Cardiology, Asklepios Klinik, St. Georg II. Med. Abteilung (Kardiologie), Lohmühlenstraße 5, 20099 Hamburg, Germany
2 Department of Cardiac Surgery, St. Georg Hospital, Hamburg, Germany
3 Institute of Experimental and Clinical Pharmacology, University Medical Center Hamburg-Eppendorf, Germany
Received 29 June 2006; revised 8 November 2006; accepted 23 November 2006.
* Corresponding author. Tel: +49 40 2890 2305; fax: +49 40 2890 4444. E-mail address: dr_c_schneider{at}hotmail.com
Aims The aim of this study was to investigate whether erythropoietin (EPO) has cardioprotective effects in a chronic myocardial ischaemia model regarding strain-rate imaging parameters during dobutamine stress echocardiography (DSE).
Methods and results An ameroid constrictor was placed around the circumflex artery in 13 pigs to induce hibernating myocardium by a chronic vessel occlusion. The pigs were randomized 14 days later: seven pigs receiving 10 000 U EPO and six pigs receiving placebo injected into the ischaemic region using a NOGATM-guided transendocardial catheter. At weeks 2 and 6, animals were examined by DSE, electromechanical mapping, and coronary angiography. During incremental dobutamine infusion, regional radial function was monitored by measuring peak systolic strain-rates (SRsys), systolic strains (
sys), and post-systolic strains (ps). At week 6, the animals were pathohistologically investigated. Echocardiography revealed 2.2 ± 0.8 hypokinetic segments in the EPO-treated animals in comparison with 3.3 ± 0.9 akinetic segments per animal in the controls. The mean ejection fraction was reduced in the control group (55 ± 3 vs. 66 ± 4%, P = 0.057). Strain-rate imaging revealed ischaemic myocardium in EPO-treated animals and non-viable myocardium in the controls (P = 0.0001). Histological analysis of the ischaemic region revealed a reduction of myocardial fibrosis (8 ± 1 vs. 27 ± 5%) in the EPO-treated group. The transmural extension of fibrosis and the echocardiographic deformation data correlated in the posterior walls (EPO group): sys at rest r = 0.83; peak SRsys during dobutamine stimulation r = 0.92, P = 0.01.
Conclusion Endocardial EPO injection may induce cardioprotective effects in chronic ischaemic myocardium and helps to obtain the myocardial contractile reserve, objectified by ultrasonic strain-rate imaging.
Key Words: Dobutamine stress echocardiography • Strain-rate imaging • Myocardial viability • Erythropoietin
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Lipsic, B. D. Westenbrink, P. van der Meer, P. van der Harst, A. A. Voors, D. J. van Veldhuisen, R. G. Schoemaker, and W. H. van Gilst Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit Eur J Heart Fail, January 1, 2008; 10(1): 22 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Westenbrink, E. Lipsic, P. van der Meer, P. van der Harst, H. Oeseburg, G. J. Du Marchie Sarvaas, J. Koster, A. A. Voors, D. J. van Veldhuisen, W. H. van Gilst, et al. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization Eur. Heart J., August 2, 2007; 28(16): 2018 - 2027. [Abstract] [Full Text] [PDF]
|
|